Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical-Cellular) Screening System

The Department investigates the molecular basis and signaling pathways associated with damage and repair in ischemic and inflammatory-based diseases associated with abdominal organs (liver, pancreas, and kidney), cancer, and cardiovascular disease but also other. idiopathic diseases such as pulmonary fibrosis.